Skip to content

Clinical trials

Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Country / region: China Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20152
20162
20191
20204
20227
20231
202411
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting18
Unknown status10
Completed6
Not yet recruiting4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China6
The First Affiliated Hospital of Soochow University6
First Affiliated Hospital of Zhejiang University5
The First Affiliated Hospital of Zhengzhou University4
Beijing Boren Hospital3
Nanfang Hospital, Southern Medical University2
Ruijin Hospital2
Sun Yat-sen University2
Betta Pharmaceuticals Co., Ltd.1
Chen Suning1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma40
Leukemia, Myeloid, Acute5
Philadelphia Chromosome4
Neoplasm, Residual3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma3
Recurrence3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2
Burkitt Lymphoma1
Leukemia1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.